Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial

Do the dissociative side effects of ketamine mediate its antidepressant effects?

(2014) David A. Luckenbaugh et al.   JOURNAL OF AFFECTIVE DISORDERS

A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013

(2014) David A. Mrazek et al.   PSYCHIATRIC SERVICES

Pilot dose–response trial of i.v. ketamine in treatment-resistant depression

(2014) Rosalyn Lai et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

(2013) James W. Murrough et al.   AMERICAN JOURNAL OF PSYCHIATRY

Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants

(2013) Jason M. Dwyer et al.   BIOLOGICAL PSYCHIATRY

Ketamine for chronic pain: risks and benefits

(2013) Marieke Niesters et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action

(2013) Marie Naughton et al.   JOURNAL OF AFFECTIVE DISORDERS

Serial infusions of low-dose ketamine for major depression

(2013) Keith G Rasmussen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR

(2013) Luli Akinfiresoye et al.   PSYCHOPHARMACOLOGY

Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression

(2012) Carlos A. Zarate et al.   BIOLOGICAL PSYCHIATRY

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

(2012) R. S. Duman et al.   SCIENCE

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

(2010) Nancy Diazgranados et al.   ARCHIVES OF GENERAL PSYCHIATRY

Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial

(2010) Wayne C. Drevets et al.   BIOLOGICAL PSYCHIATRY

Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome

(2010) Michael E. Goldberg et al.   CHIRALITY

The role and interpretation of pilot studies in clinical research

(2010) Andrew C. Leon et al.   JOURNAL OF PSYCHIATRIC RESEARCH

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

(2010) N. Li et al.   SCIENCE

A parallel chiral–achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome

(2010) Ruin Moaddel et al.   TALANTA

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1

(2009) Marnix J. Sigtermans et al.   PAIN

Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study

(2009) Robert J. Schwartzman et al.   PAIN

Development and reliability of a structured interview guide for the Montgomery-Åsberg Depression Rating Scale (SIGMA)

(2008) Janet B. W. Williams et al.   BRITISH JOURNAL OF PSYCHIATRY

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

(2008) Michael Liebrenz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases

(2008) Robert Paul et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY